The traditional patient-healthcare provider (HCP) communication model relies heavily on assumptions, made by a HCP, about what individual patients seek from their treatment.
LUNGevity’s Patient FoRCe is challenging this paradigm by:
- Quantitatively deriving patient attitudes toward specific treatments and procedures
- Empowering patients with the information they need to be active participants in their healthcare decisions
- Educating HCPs to engage their patients in treatment decision making
One such study that LUNGevity conducted and presented at the IASLC World Conference on Lung Cancer in Vienna, 2016, was Willingness for multiple biopsies to improve quality of lung cancer care: Understanding the patient perspective.